Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
ENANTA PHARMACEUTICALS INC (ENTA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G/A
| BlackRock Inc. reports a 9.4% stake in ENANTA PHARMACEUTICALS INC |
| 02/14/2023 |
SC 13G/A
| FIRST MANHATTAN CO reports a 1.2% stake in Enanta Pharmaceuticals, Inc. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.3% stake in Enanta Pharmaceuticals Inc. |
| 02/08/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
SC 13G/A
| Farallon Capital Partners, L.P. reports a 7.5% stake in Enanta Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 5.1% stake in Enanta Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 5.1% stake in Enanta Pharmaceuticals Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 5.6% stake in AMENDED FILING ENANTA PHARMACEUTICALS INC |
| 02/10/2022 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 3.5% stake in ENANTA PHARMACEUTICALS, INC. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8% stake in Enanta Pharmaceuticals Inc. |
| 02/04/2022 |
SC 13G/A
| Dworsky Alan J reports a 1% stake in ENANTA PHARMACEUTICALS, INC. |
| 01/28/2022 |
SC 13G/A
| BlackRock Inc. reports a 17.1% stake in ENANTA PHARMACEUTICALS INC |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/28/2021 |
SC 13G/A
| Dworsky Alan J reports a 6% stake in ENANTA PHARMACEUTICALS, INC. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2020 |
SC 13G/A
| BlackRock Inc. reports a 14.3% stake in ENANTA PHARMACEUTICALS INC |
| 01/23/2020 |
SC 13G/A
| Dworsky Alan J reports a 6.1% stake in ENANTA PHARMACEUTICALS, INC. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| FIRST MANHATTAN CO reports a 3.9% stake in ENANTA PHARMACEUTICALS INC |
| 02/08/2019 |
SC 13G/A
| Dworsky Alan J reports a 6.2% stake in ENANTA PHARMACEUTICALS, INC. |
| 01/28/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/22/2018 |
SC 13G/A
| Dworsky Alan J reports a 6.1% stake in ENANTA PHARMACEUTICALS, INC. |
| 01/19/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/27/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2017 |
SC 13G/A
| Dworsky Alan J reports a 6.1% stake in ENANTA PHARMACEUTICALS, INC. |
| 01/12/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/09/2016 |
SC 13G/A
| ENANTA PHARMACEUTICALS INC reports a 10.4% stake in ENANTA PHARMACEUTICALS INC |
|
|